Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
12.17
-1.08 (-8.15%)
At close: Apr 28, 2026, 4:00 PM EDT
12.17
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:27 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $484.60 million as of April 28, 2026. Its market cap has increased by 553.37% in one year.
Market Cap
484.60M
Enterprise Value
481.02M
1-Year Change
553.37%
Ranking
Category
Stock Price
$12.17
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $484.60M, a decrease of -12.45%. That is a compound annual growth rate of -5.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 530.00M | 911.49% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 631.04M |
| Absci | 602.90M |
| Aclaris Therapeutics | 597.68M |
| Zevra Therapeutics | 595.88M |
| ProKidney | 585.80M |
| Shattuck Labs | 585.00M |
| CorMedix | 581.94M |
| Prothena Corporation | 578.70M |